| Literature DB >> 33293580 |
Imran Tariq1,2, Muhammad Yasir Ali3,4, Muhammad Farhan Sohail5,6, Muhammad Umair Amin3, Sajid Ali3, Nadeem Irfan Bukhari7, Abida Raza8, Shashank Reddy Pinnapireddy3,9, Jens Schäfer3, Udo Bakowsky10.
Abstract
CliniEntities:
Mesh:
Substances:
Year: 2020 PMID: 33293580 PMCID: PMC7723038 DOI: 10.1038/s41598-020-78123-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic diagram of lipodendriplexes formation and its cellular internalization. (1) Endocytosis of lipodendriplexes and release of nucleic acid into the cytoplasm. (2) Transcription of gene-encoded DNA into mRNA. (3) Export of mRNA from the nucleus to the cytoplasm. (4) Protein expression.
Figure 2Animal experimental design: Schematic representation of acute in vivo toxicity (group 1–3) and biodistribution studies (group 4–5).
Figure 3AFM evaluation of the complexes: lock-in amplitude, height measured and lock in phase images of (a) dendriplexes and (b) DPPC:CH-PAMAM lipodendriplexes (liposome to PAMAM dendrimer mass ratio 0.5/1; N/P ratio 12/1) at intermittent contact mode using NSC14 AlBS cantilever (scale bar represents 500 nm). (c) 3D height representative view of the single lipodendriplex (image size of 0.5 μm × 0.5 μm). (d) Cross-section view of spreading lipid layer (indicated by a red arrow) showing a height of 4 nm, representing a lipid bilayer.
Figure 4Transfection and toxicity analysis in HEK-293 cell line (a) pDNA transfection studies: lipodendriplexes exhibited significant improvement in transfection efficiency in comparison to dendriplexes and free pDNA. (b) LDH release assay: dendriplexes exhibited a significant increase in LDH leakage in comparison to lipodendriplexes. (c,d) Fluorescence micrograph and relative fluorescence units (RFU) of intracellular ROS generation after the addition of dendriplexes, lipodendriplexes and tBHP (scale bar represents 20 μm). Higher DCF (green fluorescence signals) was produced from H2DCFDA after the addition of dendriplexes to the cells in comparison to lipodendriplexes. (e) Cellular protein content determination (% of control) indicating a significant decrease in protein content of dendriplexes in comparison to lipodendriplexes. Untreated cells were used as control. (f) Live/dead assay of 2D cell culture: green signals of Calcein-AM indicating the live cells while the red channel of propidium iodide signals depicting the dead cells (scale bar represents 50 μm). (g) FACS micrographs indicating; left bottom = healthy cells, right bottom = dead cells, left top = early apoptotic cells, right top = late apoptotic cells. FITC-A and PerCP-A channels indicated the bandpass fluorescence filters for Annexin V/FITC (530/30 BP) and PI (695/40 BP), respectively. (h) Graphical representation of % dead cells after treatment with different complexes. Dendriplexes mediated cellular dead is more pronounced. Values are represented as mean ± SD (n = 3) and statistical significances are indicated as **p < 0.01, ***p < 0.001.
Figure 5Transfection and toxicity analysis in HEK-293 3D spheroids (a) pCMV-GFP transfection studies in 3D spheroid: DPPC:CH-PAMAM lipodendriplexes (liposome to PAMAM dendrimer mass ratios 0.5/1; N/P ratio 12/1) exhibited higher transfection efficiency in comparison to dendriplexes. GFP expression is indicated by green fluorescence signals. Blank spheroids were without any treatment showing no fluorescence (scale bar represents 200 μm). (b) 3D cell viability assay: RLU signals are corresponding to the no. of live cells. Lipodendriplexes exhibited a significantly higher RLU values as compared to dendriplexes. (c) Live/dead assay of spheroids using CLSM: Calcein-AM green channel signals indicating the live cells while propidium iodide red channel signals depicting the dead cells (scale bar represents 100 μm). Values are represented as mean ± S.D (n = 3) and statistical significance is indicated as *p < 0.05.
Figure 6(a) Process of i.v. administration, blood collection by cardiac puncture and sacrifice of mice by cervical dislocation method, respectively. (b) Changes in body weight of mice for the 7 days in the untreated group (mice 1–3) and after the administration of the complexes containing 10 µg of pDNA (mice 4–6 dendriplexes and mice 7–9 lipodendriplexes of DPPC:CH-PAMAM; liposome to PAMAM dendrimer mass ratio 0.5/1 with N/P ratio 12/1). No changes in body weight of the mice were observed. (Arrows representing the repeated dose). (c) The organ to body index ratio of untreated group (white bar graph) and treated groups [dendriplexes (DP): black graph bar; lipodendriplexes (LDP): grey bar graph] after the sacrifice of animals by cervical dislocation. Values are represented as mean ± SD (n = 3) and statistical significance is indicated as *p < 0.05.
Figure 7Typical serum biochemical markers, erythrocytes aggregation and histopathological investigations of an untreated group and after i.v. administration of the complexes containing 10 μg of pDNA (dendriplexes and lipodendriplexes of DPPC: CH-PAMAM; liposome to PAMAM dendrimer mass ratio 0.5/1 with N/P ratio 12/1). (a) Liver function tests (LFTs) parameters including ALT, AST and ALP levels. (b) Renal function tests (RFTs) parameters including blood urea nitrogen and creatinine levels. (c) Blood glucose, total bilirubin and total protein. (d) Ex vivo erythrocytes aggregation assay after treatment of complexes with 100 μl of erythrocytes suspension (2% v/v). Scale bar represents 20 μm. (e) H&E stained sections of vital organs from mice (heart, lungs, liver and kidney). All images were taken at ×40 magnification. Scale bar represents 20 μm. Values are represented as mean ± SD (n = 3) and statistical significances are indicated as **p < 0.01, ***p < 0.001.
Haematological parameters of mice in untreated and treated (dendriplexes, lipodendriplexes) group.
| Blood parameter | Untreated | Dendriplexes | Lipodendriplexes |
|---|---|---|---|
| Hb (g/dl) | 12.9 ± 1.4 | 12.1 ± 2.0 | 12.6 ± 1.6 |
| WBCs (109/l) | 3.2 ± 1.2 | 4.4 ± 1.6* | 6.4 ± 0.8** |
| RBCs (1012/l) | 7.1 ± 1.2 | 6.6 ± 1.2* | 7.19 ± 1.9 |
| HCT (PCV) % | 35.6 ± 6.8 | 33.5 ± 6.2* | 39.2 ± 7.1* |
| MCV (fl) | 49.6 ± 5.2 | 50.0 ± 6.0 | 54.5 ± 5.6 |
| MCH (pg) | 18.0 ± 2.7 | 18.0 ± 3.1 | 17.5 ± 1.8 |
| MCHC % | 36.3 ± 8.5 | 36.1 ± 7.4 | 32.1 ± 8.1 |
| PLT (109/L) | 747.0 ± 25.2 | 794.0 ± 36.4** | 731.0 ± 19.2 |
| Neutrophils % | 10 .0 ± 1.3 | 2.0 ± 1.4*** | 2.0 ± 1.0*** |
| Lymphocytes % | 80.0 ± 9.4 | 95.0 ± 10.7* | 88.0 ± 8.1 |
| Monocytes % | 7.0 ± 1.6 | 2.0 ± 0.5*** | 8.0 ± 1.1 |
| Eosinophils % | 3.0 ± 0.8 | 1.0 ± 0.4 | 2.0 ± 0.4 |
Values are represented as mean ± S.D (n = 3) and statistical significances are indicated as *p < 0.05, **p < 0.01 and ***p < 0.001.
Figure 8Ex vivo fluorescence analysis of vital organs (heart, lungs, liver, kidneys and spleen) after i.v. administration of the complexes containing 10 μg of pCMV-GFP (dendriplexes and lipodendriplexes of DPPC:CH-PAMAM; liposome to PAMAM dendrimer mass ratio 0.5/1 with N/P ratio 12/1). The mice were sacrificed 24 h after the administration of the complexes. The organs were collected carefully and washed with normal saline to remove any blood traces. (a) Ex vivo fluorescence images using UVP iBox Explorer2 small animal imaging system using wavelength filters for green fluorescence (ex.455 nm–495 nm, em.503 nm–523 nm). Fluorescence intensity is demonstrated by a color scale bar (red depicting maximum fluorescence intensity; 65535, while dark blue is minimum fluorescence intensity; 0) and (b) quantitative biodistribution (fluorescence intensity a.u) of pCMV-GFP labeled DNA complexes in vital organs. [Black graph bar represents dendriplexes (DP) and grey bar graph represents lipodendriplexes (LDP)]. Values are represented as mean ± SD (n = 3) and statistical significances are indicated as **p < 0.01, ***p < 0.001. (c) Ex vivo fluorescence imaging in the frozen thin section of dissected vital organs (heart, lungs, liver, kidneys and spleen). Green spots indicating the GFP expression in the cells (scale bar represents 100 μm).